At first pass looks as though there is not much in the way of new patient data, although specifics on patient outcomes are good to see - based on previous data cut response rates though. Was hoping for more but expected the same.
Curious as to why they’ve left out the fact they have just achieved FDA Fast Track designation for CF33s expansion trial. Surely that’s a compelling bit of information. Given FDA approval is the ultimate goal and timelines are on everyone’s mind, I would’ve thought that would be a no brainer bit of content to a fresh audience?!
- Forums
- ASX - By Stock
- Ann: Imugene to Present at Annual JPMorgan Healthcare Conference
At first pass looks as though there is not much in the way of...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1082545 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 603058 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1082545 | 0.055 |
11 | 751779 | 0.054 |
16 | 3014424 | 0.053 |
22 | 1646348 | 0.052 |
17 | 4842977 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 603058 | 6 |
0.058 | 1247143 | 8 |
0.059 | 324318 | 2 |
0.060 | 1512398 | 12 |
0.061 | 1091000 | 7 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |